Misplaced Pages

:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox: Difference between revisions - Misplaced Pages

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
< Misplaced Pages:WikiProject Chemicals | Chembox validation Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 11:01, 20 February 2012 editBeetstra (talk | contribs)Edit filter managers, Administrators172,084 edits Saving copy of the {{drugbox}} taken from revid 456641132 of page Traxoprodil for the Chem/Drugbox validation project (updated: 'CAS_number').← Previous edit Revision as of 11:02, 20 February 2012 edit undoBeetstra (talk | contribs)Edit filter managers, Administrators172,084 edits Saving copy of the {{drugbox}} taken from revid 469541507 of page Treprostinil for the Chem/Drugbox validation project (updated: 'ChEMBL', 'CAS_number').Next edit →
Line 1: Line 1:
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid of page ] with values updated to verified values.}} {{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid of page ] with values updated to verified values.}}
{{Drugbox {{Drugbox
| Verifiedfields = changed | Verifiedfields = changed
| verifiedrevid = 426610639 | verifiedrevid = 431682874
| IUPAC_name = (1''R'',2''R'',3a''S'',9a''S'')-<nowiki>-1''H''-benzinden-5-yl]<br>oxy]acetic acid
| IUPAC_name = (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol
| image = Traxoprodil_structure.png | image = Treprostinil.svg
| image2 = Treprostinil2.png
| width = 260


<!--Clinical data--> <!--Clinical data-->
| tradename = | tradename = Remodulin, Tyvaso
| Drugs.com = {{drugs.com|CONS|treprostinil}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| MedlinePlus = a600042
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = | pregnancy_category = B
⚫ | legal_status = Rx-only
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| routes_of_administration = ] or ], inhalation
| legal_CA = <!-- Schedule I -->
| legal_UK = <!-- Class A -->
| legal_US =
⚫ | legal_status =


<!--Pharmacokinetic data--> <!--Pharmacokinetic data-->
| bioavailability = | bioavailability = approximately 100%
| metabolism = Treprostinil is substantially metabolized by the liver, but the involved enzymes are not currently known. Five metabolites (HU1 through HU5) have been described thus far. Based on the results of in vitro human hepatic cytochrome P450 studies, Remodulin does not inhibit CYP-1A2, 2C9, 2C19, 2D6, 2E1, or 3A. Whether Remodulin induces these enzymes has not been studied.
| protein_bound =
| elimination_half-life = 4 hours
| metabolism =
| excretion = Urine (79 % of administered dose is excreted in the urine as 4% unchanged drug and 64% as identified metabolites); feces (13%)
| excretion =


<!--Identifiers--> <!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}} | CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = <!-- blanked - oldvalue: 134234-12-1 --> | CAS_number = <!-- blanked - oldvalue: 289480-64-4 -->
| ATC_prefix = B01
| CAS_supplemental = <BR/>189894-57-3 (methanesulphonate)
| ATC_prefix = none | ATC_suffix = AC21
| ATC_suffix = | PubChem = 6918140
⚫ | DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| PubChem = 219101
⚫ | DrugBank = DB00374
⚫ | DrugBank_Ref = {{drugbankcite|correct|drugbank}}
⚫ | DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 189919 | ChemSpiderID = 5293353
| UNII_Ref = {{fdacite|changed|FDA}} | UNII_Ref = {{fdacite|changed|FDA}}
| UNII = UTC046R5HM | UNII = RUM6K67ESG
| ChEMBL_Ref = {{ebicite|changed|EBI}} | ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 17350 | ChEBI = 50861
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| synonyms = Traxoprodil, CP-101,606
| ChEMBL = <!-- blanked - oldvalue: 1201254 -->

⚫ | C=23 | H=34 | O=5
<!--Chemical data-->
⚫ | molecular_weight = relative molecular weight is 390.52 g/mol.
⚫ | C=20 | H=25 | N=1 | O=3
⚫ | StdInChI_Ref = {{stdinchicite|changed|chemspider}}
⚫ | molecular_weight = 327.416 g/mol
| StdInChI = 1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1
| smiles = c2cc(O)ccc2C(O)C(C)N3CCC(O)(CC3)c1ccccc1
⚫ | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H25NO3/c1-15(19(23)16-7-9-18(22)10-8-16)21-13-11-20(24,12-14-21)17-5-3-2-4-6-17/h2-10,15,19,22-24H,11-14H2,1H3/t15-,19+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QEMSVZNTSXPFJA-HNAYVOBHSA-N | StdInChIKey = PAJMKGZZBBTTOY-ZFORQUDYSA-N
}} }}

Revision as of 11:02, 20 February 2012

This page contains a copy of the infobox ({{drugbox}}) taken from revid 469541507 of page Treprostinil with values updated to verified values.
WikiProject Chemicals/Chembox validation/VerifiedDataSandbox
Clinical data
Trade namesRemodulin, Tyvaso
AHFS/Drugs.comMicromedex Detailed Consumer Information
MedlinePlusa600042
Pregnancy
category
  • B
Routes of
administration		Subcutaneous or intravenous infusion, inhalation
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailabilityapproximately 100%
MetabolismTreprostinil is substantially metabolized by the liver, but the involved enzymes are not currently known. Five metabolites (HU1 through HU5) have been described thus far. Based on the results of in vitro human hepatic cytochrome P450 studies, Remodulin does not inhibit CYP-1A2, 2C9, 2C19, 2D6, 2E1, or 3A. Whether Remodulin induces these enzymes has not been studied.
Elimination half-life4 hours
ExcretionUrine (79 % of administered dose is excreted in the urine as 4% unchanged drug and 64% as identified metabolites); feces (13%)
Identifiers
IUPAC name
  • (1R,2R,3aS,9aS)--1H-benzinden-5-yl]
    oxy]acetic acid
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
Chemical and physical data
FormulaC23H34O5
Molar massrelative molecular weight is 390.52 g/mol. g·mol
InChI
  • InChI=1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1
  • Key:PAJMKGZZBBTTOY-ZFORQUDYSA-N
  (what is this?)  (verify)
Misplaced Pages:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox: Difference between revisions Add topic